Baxter completed the separation process of its Korea branch, launching ‘Baxalta’

The separation process of a biopharmaceutical company from the Baxter’s Korean branch has been completed.

According to the industry concerned on the 6^th, Baxter Korea turned in reports registering a merger and a new corporate to the Fair Trade Commission this early-year, completed preparation of various detailed matters, such as manpower reorganization and separated the company into Baxter and...